Company intelligence / Profile preview

Gemoscan International

Toronto, Ontario, Canada
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

Gemoscan was a healthcare company specializing in food intolerance management and dietary wellness solutions. Headquartered in Toronto, the company developed and commercialized the HEMOCODE System, a proprietary blood-based diagnostic tool used to identify food sensitivities and provide personalized nutritional guidance. Gemoscan also operated a network of multidisciplinary paramedical clinics and established partnerships with major retail pharmacies to distribute its services across Canada and the United States. Its programs were designed as adjuncts to conventional medical practices, focusing on improving patient well-being through lifestyle and dietary modifications. The company ceased operations and filed for bankruptcy in early 2016 due to financial difficulties.

Therapeutic areas
ImmunologyEndocrinologyNeurologyRheumatologyGastroenterology
Modalities
DiagnosticNon-pharmacological therapy
Industry
Protein Biomarker Diagnostics
02

Partnerships

American Metabolic Testing Laboratories, Inc.

Beyond the preview

Go deeper on Gemoscan International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gemoscan International.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call